Loading...
Loading...
ALTERITY THERAPEUTICS LTD
ALTERITY THERAPEUTICS LTD. Spoken Alpha tracks ATHE's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks ATHE's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ATHE.
curl https://api.spokenalpha.com/v1/companies/ATHE| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $5.83 | $4.12 | +41.5% | -1.0% | +0.5% |
| Q4 FY2026 | $5.48 | $4.23 | +29.6% | -3.4% | -3.7% |
| Q3 FY2026 | $5.48 | $4.14 | +32.3% | -3.4% | -3.6% |
| Q2 FY2026 | $5.80 | $4.20 | +38.1% | +4.9% | +3.2% |
| Q1 FY2025 | $5.53 | $4.19 | +32.1% | -3.1% | -3.2% |
| Q4 FY2025 | $6.06 | $4.35 | +39.4% | +1.6% | +1.6% |
| Q3 FY2025 | $5.99 | $4.45 | +34.7% | -0.2% | -0.8% |
| Q2 FY2025 | $5.83 | $4.43 | +31.6% | -0.8% | -0.5% |
| Q1 FY2024 | $5.66 | $4.35 | +30.1% | +2.9% | +3.7% |
| Q4 FY2024 | $5.86 | $4.34 | +35.1% | +0.3% | +0.4% |